Clinical Trials on 残留胶质瘤 in United States
总计1962个结果
-
University of PennsylvaniaUniversity of California, San Francisco终止
-
National Cancer Institute (NCI)招聘中
-
Institut de Recherches Internationales Servier主动,不招人复发性胶质瘤 | 2 级神经胶质瘤 | 残留胶质瘤美国, 加拿大, 西班牙, 意大利, 英国, 瑞士, 以色列, 日本, 荷兰, 德国, 法国
-
M.D. Anderson Cancer Center主动,不招人
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)撤销
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
University of Colorado, DenverAstraZeneca完全的
-
National Heart, Lung, and Blood Institute (NHLBI)完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者完全的胶质母细胞瘤 | 胶质肉瘤 | 恶性胶质瘤美国
-
University of Maryland, Baltimore主动,不招人
-
National Cancer Institute (NCI)完全的复发性高级别胶质瘤 | 恶性胶质瘤 | Progressive Low-Grade Gliomas美国
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的
-
Washington University School of MedicineTaiho Oncology, Inc.招聘中
-
Abramson Cancer Center at Penn Medicine招聘中
-
M.D. Anderson Cancer CenterBioMed Valley Discoveries, Inc招聘中
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)招聘中
-
UNC Lineberger Comprehensive Cancer Center完全的
-
Luca SzalontayMidatech Pharma US Inc.完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.招聘中急性髓性白血病 | 治疗相关的急性髓性白血病 | 血液和淋巴细胞疾病 | 缓解期急性髓性白血病 | FLT3基因突变 | 最小残留病持续存在美国
-
Robert Bok, MD, PhDNational Cancer Institute (NCI)招聘中
-
Memorial Sloan Kettering Cancer CenterPfizer撤销
-
Cheng-Chia (Fred) WuFocused Ultrasound Foundation主动,不招人
-
Tactical Therapeutics, Inc.主动,不招人
-
UNC Lineberger Comprehensive Cancer Center主动,不招人
-
University of FloridaCelgene Corporation终止骨髓增生异常综合征 | 白血病,骨髓美国